All In Biotech

Free tool

FAERS Monitor: Zenpep

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 022210 or its brand name (Zenpep, Pancrelipase (Amylase, Lipase, Protease)). Reports on generic versions are filed under their own applications.

Reports

6,026

Serious

3,528

59% of reports

Hospitalization

2,308

Death reported

408

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea500
  • infective pulmonary exacerbation of cystic fibrosis451
  • hospitalisation329
  • death296
  • cystic fibrosis287
  • nausea279
  • headache255
  • fatigue238
  • pneumonia233
  • weight decreased222
  • drug ineffective209
  • abdominal pain205
  • dyspnoea201
  • constipation200
  • cough198

Reports by year received

View as table
YearReports
201010
201110
201225
201359
2014100
2015217
2016333
2017337
2018541
2019944
2020778
2021318
2022370
2023562
2024544
2025518
2026360

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,133 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infective pulmonary exacerbation of cystic fibrosisSignal451315.2287.3129,326
cystic fibrosisSignal287190.8169.951,204
hospitalisationSignal3297.56.71,852
constipationSignal2003.22.8304
abdominal painSignal2053.12.7288
weight decreasedSignal2222.82.4254
diarrhoeaSignal5002.72.5552
pneumoniaSignal2332.52.2214
coughSignal1982.52.1173
headache2551.41.332
dyspnoea2011.21.19
nausea2791.21.112
death2961.21.110
fatigue2381.10.91
drug ineffective2090.60.580

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.